Table 1.
Patient demographic information for those who did and did not view pre-consult patient educational videos.
|
Participated in the education cohort N=30 (57.7 %) |
Did not participate in the education cohort N=22 (42.3 %) |
P-value* | |
|---|---|---|---|
| Age in years; median [IQR] | 61 [56–69] | 63 [50–68] | 0.99 |
| Gender; N (%) Men Women |
5 (16.7 %) 25 (83.3 %) |
1 (4.5 %) 21 (95.5 %) |
0.18 |
| Race; N (%) Asian Black Native American/Alaska Native Native Hawaiian/Pacific Islander White |
0 (0 %) 1 (3.3 %) 1 (3.3 %) 0 (0 %) 28 (93.3 %) |
0 (0 %) 1 (4.5 %) 0 (0 %) 0 (0 %) 21 (95.5 %) |
0.67 |
| Ethnicity; N (%) Hispanic/Latino Non-Hispanic/Latino |
1 (3.3 %) 29 (96.7 %) |
2 (9.1 %) 20 (90.9 %) |
0.38 |
| HIV Status; N (%) Negative Positive Unknown |
26 (86.7 %) 3 (10 %) 1 (3.3 %) |
21 (95.5 %) 0 (0 %) 1 (4.5 %) |
0.31 |
| Sexual Orientation; N (%) Heterosexual Homosexual Bisexual Other Prefer not to say |
26 (86.7 %) 2 (6.7 %) 0 (0 %) 0 (0 %) 2 (6.7 %) |
20 (90.9 %) 2 (9.1 %) 0 (0 %) 0 (0 %) 0 (0 %) |
0.45 |
| T-Stage; N (%) T1 T2 T3 T4 |
8 (26.7 %) 14 (46.7 %) 6 (20 %) 2 (6.7 %) |
4 (18.2 %) 11 (50 %)2 (9.1 %) 5 (22.7 %) |
0.28 |
| N-Stage; N (%) N0 N1a N1b N1c |
19 (63.3 %) 9 (30 %) 0 (0 %) 2 (6.7 %) |
7 (31.8 %) 13 (59.1 %) 0 (0 %) 2 (9.1 %) |
0.08 |
| Radiation Dose; N (%) 50 Gray 54 Gray 58 Gray Other |
10 (33.3 %) 12 (40 %) 7 (23.3 %) 1 (3.3 %) |
3 (13.6 %) 10 (45.5 %) 9 (40.9 %) 0 (0 %) |
0.25 |
*Pearson Chi-square test for categorical variables and Kruskal-Wallis test for continuous variables. HIV=human immunodeficiency virus; T = tumor, N=nodal.